BEGHE', Bianca
 Distribuzione geografica
Continente #
NA - Nord America 18.062
AS - Asia 7.665
EU - Europa 7.291
SA - Sud America 1.132
AF - Africa 183
OC - Oceania 54
Continente sconosciuto - Info sul continente non disponibili 6
Totale 34.393
Nazione #
US - Stati Uniti d'America 17.875
SG - Singapore 2.460
GB - Regno Unito 2.354
CN - Cina 1.973
IT - Italia 1.801
HK - Hong Kong 1.042
BR - Brasile 860
VN - Vietnam 798
SE - Svezia 531
DE - Germania 512
FI - Finlandia 462
UA - Ucraina 353
RU - Federazione Russa 310
FR - Francia 308
KR - Corea 248
TR - Turchia 217
ID - Indonesia 207
IN - India 156
BG - Bulgaria 152
AR - Argentina 92
BD - Bangladesh 79
NL - Olanda 79
MX - Messico 78
CA - Canada 74
IQ - Iraq 70
ZA - Sudafrica 66
PK - Pakistan 60
CO - Colombia 57
ES - Italia 55
AU - Australia 49
IE - Irlanda 44
JP - Giappone 44
RO - Romania 43
AT - Austria 41
AE - Emirati Arabi Uniti 37
MY - Malesia 34
PL - Polonia 34
CL - Cile 30
LT - Lituania 30
VE - Venezuela 30
BE - Belgio 28
IR - Iran 27
CH - Svizzera 26
EC - Ecuador 26
SA - Arabia Saudita 22
PH - Filippine 20
TH - Thailandia 18
NP - Nepal 17
JO - Giordania 16
PY - Paraguay 16
RS - Serbia 16
KE - Kenya 15
UZ - Uzbekistan 15
PT - Portogallo 14
TW - Taiwan 14
CZ - Repubblica Ceca 13
EG - Egitto 13
MA - Marocco 13
SY - Repubblica araba siriana 13
TN - Tunisia 13
AL - Albania 10
DO - Repubblica Dominicana 10
DZ - Algeria 10
IL - Israele 10
KZ - Kazakistan 10
UY - Uruguay 9
AZ - Azerbaigian 8
BF - Burkina Faso 8
ET - Etiopia 8
MD - Moldavia 8
NO - Norvegia 8
PE - Perù 8
SI - Slovenia 8
HU - Ungheria 7
OM - Oman 7
EE - Estonia 6
LB - Libano 6
NG - Nigeria 6
AO - Angola 5
BH - Bahrain 5
DK - Danimarca 5
GR - Grecia 5
KG - Kirghizistan 5
LV - Lettonia 5
MK - Macedonia 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
BY - Bielorussia 4
LY - Libia 4
MN - Mongolia 4
PA - Panama 4
PR - Porto Rico 4
QA - Qatar 4
SN - Senegal 4
CG - Congo 3
EU - Europa 3
GA - Gabon 3
Totale 34.342
Città #
Ashburn 1.634
Fairfield 1.600
Southend 1.573
Singapore 1.469
Santa Clara 1.421
Hong Kong 1.023
Woodbridge 979
Chandler 931
Houston 833
Hefei 674
Jacksonville 661
Chicago 622
San Jose 589
Seattle 570
Wilmington 563
Cambridge 513
Dearborn 504
London 416
Los Angeles 402
Ann Arbor 360
Beijing 349
Helsinki 337
Salt Lake City 282
New York 251
Modena 243
Nyköping 240
Ho Chi Minh City 232
Hanoi 224
Seoul 222
The Dalles 212
Council Bluffs 202
San Diego 188
Milan 176
Princeton 161
Dallas 157
Tampa 148
Sofia 146
Elk Grove Village 133
Rome 122
Eugene 116
Lauterbourg 113
Jakarta 94
São Paulo 94
Izmir 93
Buffalo 87
Moscow 83
Redwood City 75
Des Moines 72
Shanghai 67
Frankfurt am Main 66
Lancaster 65
Naples 61
Sterling 60
Columbus 50
Boardman 47
Da Nang 43
Orem 43
Miami 40
Nuremberg 38
Dublin 37
Falls Church 35
Phoenix 35
Atlanta 34
Detroit 34
Tokyo 34
Bologna 32
Bogotá 29
Grafing 29
Munich 28
Kansas City 27
Redondo Beach 27
Ankara 26
Haiphong 26
Kent 26
Mexico City 26
Rio de Janeiro 26
Dulles 25
Florence 25
Norwalk 25
Baghdad 24
Belo Horizonte 24
Chennai 24
Johannesburg 23
Verona 23
Warsaw 23
San Francisco 22
Toronto 22
Nanjing 21
Vienna 21
Brooklyn 19
Brussels 19
Buenos Aires 19
Montreal 19
Saint Petersburg 18
Jersey City 17
Miano 17
Timisoara 17
Amsterdam 16
Bari 16
Guangzhou 16
Totale 23.775
Nome #
The genetic basis of atopic asthma. 820
Asma bronchiale 657
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 478
The Burden of Image Based Emphysema and Bronchiolitis in HIV-Infected Individuals on Antiretroviral Therapy 474
Chronic respiratory abnormalities in the multi-morbid frail elderly 382
Three-year hospitalization and mortality in elderly smokers with COPD or CHF. 378
Acute severe asthma: management and treatment. 371
Airway inflammation in childhood asthma 366
Physiologic consequences of long term inflammation 350
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 349
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. 346
Comparison of two methods of processing induced sputum: selected versus entire sputum. 342
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections 332
Update in Chronic Obstructive Pulmonary Disease 2005 331
Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure 329
La broncopneumopatia cronica ostruttiva nell'anziano 329
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis 328
Lack of association of HLA class I genes and TNF alpha-308 polymorphism in toluene diisocyanate-induced asthma. 324
Exacerbation of respiratory Symptoms in COPD patients may not be exacerbations of COPD 318
Microsatellite alterations suggestive of organ-specific asthma and atopy in exhaled breath condensate 316
Update in chronic obstructive pulmonary disease 2006 315
Comparison of three methods for single nucleotide polymorphism typing for DNA bank studies: sequence-specific oligonucleotide probe hybridisation, TaqMan liquid phase hybridisation, and microplate array diagonal gel electrophoresis (MADGE). 314
Treatment of chronic obstructive pulmonary disease and its comorbidities 314
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 313
Roflumilast:un nuovo farmaco per il trattamento della BPCO 309
Linkage analysis of the 5q31-33 candidate region for asthma in 240 UK families. 307
Acute exacerbations of chronic obstructive pulmonary disease provide a unique opportunity to take care of patients 307
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 307
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 305
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 305
Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease 303
Complex chronic co-morbidities of COPD 302
Transforming growth factor-β type II receptor in pulmonary arteries of patients with very severe COPD 301
Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma. 299
Inhaled Corticosteroids in COPD: Pros and Cons. 297
Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population. 296
Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed? 290
La genetica dell’asma bronchiale. 288
Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. 282
Cardiovascular mechanisms of death in severe COPD exacerbation: time to think and act beyond guidelines 280
Role for CXCR6 and its Ligand CXCL16 in the Pathogenesis of T-cell Alveolitis in Sarcoidosis 276
The cysteinyl-leukotriene type 1 receptor polymorphism 927T/C is associated with atopy severity but not with asthma 275
Baseline exercise tolerance and perceived dyspnea to identify the ideal candidate to pulmonary rehabilitation: a risk chart in COPD patients. 272
COPD and the Solar System:Introducing the Chronic Obstructive Pulmonary Disease Comorbidome 270
We Have to Learn to Do Without Knowing Enough: Anti-Eosinophilic Treatments for Severe Asthma 269
[Pathology of chronic obstructive pulmonary disease] 269
Leukotriene B4 receptor locus gene characterisation and association studies in asthma 268
Alveolar and bronchiolar inflammation in COPD 268
Eosinophilia in asthma: the easy way is not always the best 258
Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice 256
Quality of life and intrinsic capacity in patients with post-acute COVID-19 syndrome is in relation to frailty and resilience phenotypes. 254
Pulmonary comorbidities associated with chronic obstructive pulmonary disease 253
Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease 253
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs 249
Polymorphisms in the interleukin-4 and interleukin-4 receptor α chain genes confer susceptibility to asthma and atopy in a Caucasian population 249
Basi strutturali della BPCO. 247
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 247
Significant chronic airway abnormalities in never-smoking HIV-infected patients 242
La NIV nel paziente con insufficienza respiratoria cronica, la gestione domiciliare - Competenza specialistica nelle patologie pneumologiche pure 241
Nasal pressure swings as the measure of inspiratory effort in spontaneously breathing patients with de novo acute respiratory failure 238
Phosphodiesterase-4 Inhibitor Therapy for Lung Diseases 234
The multiple components of COPD 232
Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome. 230
Tissue polypeptide specific antigen (tps) and cytokeratin 19 fragment (CYFRA 21.1) immunoradiometric assay in non small cell lung cancer evaluation. 229
Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice 229
Genetic influences on Asthma Severity. 228
Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis 224
Triple therapy for symptomatic patients with COPD 222
Chronic Obstructive Pulmonary Disease is just one component of the complex multimorbidities in patients with COPD. 219
What is the origin of dyspnoea in smokers without airway disease ? 219
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 218
Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease. 212
Copd, pulmonary fibrosis and ilas in aging smokers: The paradox of striking different responses to the major risk factors 211
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. 209
Pathology of COPD and asthma 208
Identifying and Treating COPD in Cardiac Patients 207
Evaluation of the serum markers CEA, NSE, TPS and CYFRA 21.1 in lung cancer. 206
Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials 205
Peripheral eosinophil count as a biomarker for the management of COPD: not there yet. 203
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. 200
Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. 198
Asthma 198
Reply: look at the moon, not just at the finger indicating the moon 198
Trattamento farmacologico dell’asma bronchiale 197
Neutrophilic infiltration within the airway smooth muscle in patients with COPD 197
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) 196
Update in Asthma 2016 193
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 192
Cardiac Diseases and respiratory consequences 191
Blood eosinophils for the management of COPD patients? 188
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact 188
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation 184
COPD in the elderly is almost invariably associated with one or more chronic comorbidities 181
Airway inflammation in severe chronic obstructive pulmonary disease - Relationship with lung function and radiologic emphysema 179
Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema 177
Trattamento farmacologico dell’asma bronchiale. 175
La broncopneumopatia cronica ostruttiva 174
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology 174
Symptomatic elderly patients. The urgent need for comprehensive assessment and management 172
Pharmacological prevention of COPD exacerbations 170
Totale 27.175
Categoria #
all - tutte 148.750
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.750


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021373 0 0 0 0 0 0 0 0 0 0 231 142
2021/20222.918 100 297 234 234 95 132 169 157 341 262 562 335
2022/20232.487 256 256 133 224 288 357 83 276 345 64 107 98
2023/20242.004 83 140 115 265 356 207 130 215 87 92 117 197
2024/20256.247 227 176 100 410 1.111 940 290 268 717 346 681 981
2025/202610.877 634 463 881 1.607 2.465 830 1.380 487 941 910 279 0
Totale 34.650